首页 | 本学科首页   官方微博 | 高级检索  
     


Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cells
Authors:Joseph R. Leventhal  Joshua Miller  James M. Mathew  Sunil Kurian  Anat R. Tambur  John Friedewald  Jane Charrette  Michael M. Abecassis
Affiliation:1. Comprehensive Transplant Center, Department of Surgery, Northwestern University, Chicago, IL, USA;2. Department of Microbiology-Immunology, Northwestern University, Chicago, IL, USA;3. Department of Molecular and Experimental Medicine, The Scripps Research Institute and Scripps Center for Organ Transplantation, La Jolla, CA, USA;4. Division of Nephrology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Abstract:Kidney transplant recipients given donor hematopoietic stem cells from their HLA-identical living related donors have now been followed between 5 and 9½ years post-operatively. Recipients who were designated as tolerant (Tol) have remained so since the last report when the 5?year (biopsy associated) milestone was reached. There has been 1 mortality of a Tol patient, unrelated to the study protocol, while 5 (of 15) have remained Tol between 7 and 8½ years post-operatively. There has been continuing elevated T-regulatory (CD4+CD25HighCD127?FOXP3+) cells in PBMC previously reported on. Ten year renal transplant biopsies are tentatively planned.
Keywords:Tolerance  HLA-identical renal transplants  T and B regulatory cells  Genomic markers
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号